文献速递介入外周血管DSA

下肢血管造影 CNR 驱动曝光控制的辐射剂量与图像质量前瞻性研究

Prospective study to evaluate radiation dose and image quality in two-dimensional (2D) lower limb angiographic images acquired with a novel contrast-to-noise ratio (CNR)-driven exposure control protocol.
PubMed 文献 · Clin Radiol · 2026-08-27

本研究对 40 例下肢血管成形术患者随机采用新型 CNR 驱动曝光控制方案 OPTIQ 或常规剂量方案。OPTIQ 显著降低患者总 DAP、二维造影 DAP 及空气比释动能,降幅约 60%,操作者散射剂量更低但差异未达统计学意义。两组主观图像质量无显著差异,均满足诊断要求。

要点

  • OPTIQ 方案可在不降低图像质量前提下显著降低约 60% 辐射剂量
  • 二维血管造影 DAP 降幅最大,可优先用于下肢介入透视场景
  • 操作者散射剂量有下降趋势但无统计学差异,仍需常规防护

核心结论

  • 采用 OPTIQ 方案可在下肢血管成形术中降低患者和操作者的辐射剂量,同时不损害诊断图像质量,符合 ALARA 原则

研究设计与样本

  • 研究类型为前瞻性随机对照研究,样本量为 40 例下肢血管成形术患者
  • 随机分为 CDP 常规剂量方案组和 OPTIQ 新型 CNR 驱动曝光控制方案组
  • 患者辐射剂量用剂量面积乘积和空气比释动能评估,操作者用实时剂量计测量散射辐射

关键影像表现/征象

  • OPTIQ 组总 DAP 为 412.8 ± 318.2 μGym2,CDP 组为 1,284.5 ± 841.2 μGym2,差异有统计学意义
  • 二维造影 DAP 在 OPTIQ 组为 132.0 ± 92.5 μGym2,CDP 组为 1,059.3 ± 640.4 μGym2,差异有统计学意义
  • 两组对比度、亮度、锐利度及器械显示的主观评分均无显著差异
  • 两种方案获取的图像均达到诊断可接受水平

诊断标准与关键数值

  • OPTIQ 组总空气比释动能为 19.9 ± 16.9 mGy,CDP 组为 55.0 ± 45.3 mGy,P<0.005
  • 总 DAP 比较 P<0.001,二维造影 DAP 比较 P<0.001
  • 主观图像质量采用 5 分 Likert 量表评估,各参数组间比较 P>0.05
  • 操作者辐射暴露 OPTIQ 组为 0.138 ± 0.135 μSv/sec,CDP 组为 0.362 ± 0.632 μSv/sec,P=0.288

临床应用与阅片要点

  • OPTIQ 方案可用于下肢血管成形术中常规透视和二维血管造影的剂量优化
  • 阅片时两种方案图像质量无显著差异,无需因剂量降低而改变诊断信心
  • 介入操作中采用 CNR 驱动曝光控制有助于落实 ALARA 原则

局限性

  • 研究为单中心设计,样本量为 40 例
  • 操作者辐射暴露差异未达到统计学意义,可能受样本量限制

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

AIM: Radiation exposure during peripheral vascular intervention poses potential deterministic and stochastic risks in the long run to patients and operators. Thus, it is important to optimise radiation dose without compromising on image quality. OPTIQ, a novel contrast-to-noise ratio (CNR)-driven exposure control, is prospectively evaluated against conventional dose protocol (CDP) to determine differences in radiation dose and image quality.

MATERIALS AND METHODS: Forty lower limb angioplasty cases between April 2023 and March 2025 were randomly assigned to either CDP or OPTIQ protocol for prospective evaluation. Primary outcomes included radiation dose measured by dose-area product (DAP) and air kerma (AK) for patients and scattered radiation exposure for operators using real-time dosimeters. Secondary outcomes assessed subjective image quality using 5-point Likert scales for contrast, brightness, sharpness, and device visualisation.

RESULTS: Patient demographics were comparable between groups. OPTIQ demonstrated significant radiation dose reduction compared to CDP: total DAP (412.8 ± 318.2 vs 1,284.5 ± 841.2 μGym2, P<0.001), two-dimensional (2D) angiography DAP (132.0 ± 92.5 vs 1,059.3 ± 640.4 μGym2, P<0.001), and total AK (19.9 ± 16.9 vs 55.0 ± 45.3 mGy, P<0.005). Total radiation dose reduced by approximately 60% with OPTIQ. Operator radiation exposure was lower with OPTIQ (0.138 ± 0.135 vs 0.362 ± 0.632 μSv/sec, P=0.288), though not statistically significant. Subjective image quality assessments showed no significant differences between protocols across all parameters (P>0.05), with both protocols providing diagnostically acceptable images.

CONCLUSION: The adoption of OPTIQ protocol can bring about radiation-dose reduction for both patients and healthcare workers during lower limb angioplasty without compromising diagnostic image quality, which is in line with As Low As Reasonably Achievable (ALARA) principles.

来源:Clin Radiol,查看原文。版权归原作者所有。

引用

  1. Yap, Kim, Resurreccion, et al. Prospective study to evaluate radiation dose and image quality in two-dimensional (2D) lower limb angiographic images acquired with a novel contrast-to-noise ratio (CNR)-driven exposure control protocol. Clin Radiol. 2026. PMID: 42762685. doi:10.1016/j.crad.2026.107467

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。